EP1667681A4 - A novel transmucosal delivery system - Google Patents
A novel transmucosal delivery systemInfo
- Publication number
- EP1667681A4 EP1667681A4 EP04745093A EP04745093A EP1667681A4 EP 1667681 A4 EP1667681 A4 EP 1667681A4 EP 04745093 A EP04745093 A EP 04745093A EP 04745093 A EP04745093 A EP 04745093A EP 1667681 A4 EP1667681 A4 EP 1667681A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- delivery system
- transmucosal delivery
- novel
- novel transmucosal
- transmucosal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1027MU2003 | 2003-10-03 | ||
PCT/IN2004/000013 WO2005032554A1 (en) | 2003-10-03 | 2004-01-20 | A novel transmucosal delivery system |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1667681A1 EP1667681A1 (en) | 2006-06-14 |
EP1667681A4 true EP1667681A4 (en) | 2009-09-30 |
Family
ID=34401273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04745093A Withdrawn EP1667681A4 (en) | 2003-10-03 | 2004-01-20 | A novel transmucosal delivery system |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1667681A4 (en) |
WO (1) | WO2005032554A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007083984A1 (en) | 2006-01-23 | 2007-07-26 | Gwangju Institute Of Science And Technology | Conjugate comprising pharmaceutical active compound covalently bound to mucoadhesive polymer and transmucosal delivery method of pharmaceutical active compound using the same |
AR056062A1 (en) | 2006-06-05 | 2007-09-19 | Bago Sa Labor | ANTI-AGED PHARMACEUTICAL COMPOSITION IN DUST FORM, PHARMACEUTICAL PREPARATION THAT UNDERSTANDS IT AND PROCESS FOR PREPARATION |
WO2008067037A2 (en) * | 2006-10-05 | 2008-06-05 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
FR2972327B1 (en) * | 2011-03-11 | 2017-08-11 | Laboratoires Le Stum | MUCOADHESIVE NUTRACEUTICAL COMPOSITION COMPRISING ANTIOXIDANT ASSOCIATION |
IT201700124434A1 (en) * | 2017-10-31 | 2019-05-01 | Sofar Swiss Sa | Tablet to suck and / or dissolve in the mouth based on hyaluronic acid and chondroitin sulfate and their salts for use in the treatment of a subpopulation of GERD patients. |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0567201A2 (en) * | 1986-04-30 | 1993-10-27 | Aktiebolaget Hässle | Vehicles for oral administration of a specific pharmaceutically active acid labile substance |
WO1997012580A2 (en) * | 1995-09-21 | 1997-04-10 | Pharma Pass Llc | Novel composition containing an acid-labile benzimidazole and process for its preparation |
WO1998052564A1 (en) * | 1997-05-23 | 1998-11-26 | Cipla Limited | Benzimidazole pharmaceutical composition and process of preparation |
WO1999029320A1 (en) * | 1997-12-08 | 1999-06-17 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Novel administration form comprising an acid-labile active compound |
US6294586B1 (en) * | 1998-05-05 | 2001-09-25 | Sepracor Inc. | Hydroxyomeprazole compositions and methods |
US6489346B1 (en) * | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5885565A (en) | 1993-03-19 | 1999-03-23 | Cellegy Pharmaceuticals Inc. | Methods for inducing phase separation of epithelial lipid bilayers |
SI0869772T1 (en) | 1995-12-27 | 2002-04-30 | Janssen Pharmaceutica N.V. | Bioadhesive solid dosage form |
SE9600070D0 (en) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
US6296876B1 (en) | 1997-10-06 | 2001-10-02 | Isa Odidi | Pharmaceutical formulations for acid labile substances |
JP4065642B2 (en) | 2000-02-24 | 2008-03-26 | 扶桑薬品工業株式会社 | Composition for prevention and treatment of digestive system diseases |
-
2004
- 2004-01-20 WO PCT/IN2004/000013 patent/WO2005032554A1/en active Application Filing
- 2004-01-20 EP EP04745093A patent/EP1667681A4/en not_active Withdrawn
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0567201A2 (en) * | 1986-04-30 | 1993-10-27 | Aktiebolaget Hässle | Vehicles for oral administration of a specific pharmaceutically active acid labile substance |
WO1997012580A2 (en) * | 1995-09-21 | 1997-04-10 | Pharma Pass Llc | Novel composition containing an acid-labile benzimidazole and process for its preparation |
US6489346B1 (en) * | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
WO1998052564A1 (en) * | 1997-05-23 | 1998-11-26 | Cipla Limited | Benzimidazole pharmaceutical composition and process of preparation |
WO1999029320A1 (en) * | 1997-12-08 | 1999-06-17 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Novel administration form comprising an acid-labile active compound |
US6294586B1 (en) * | 1998-05-05 | 2001-09-25 | Sepracor Inc. | Hydroxyomeprazole compositions and methods |
Non-Patent Citations (1)
Title |
---|
See also references of WO2005032554A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1667681A1 (en) | 2006-06-14 |
WO2005032554A1 (en) | 2005-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2429924B (en) | Delivery devices | |
GB2404867B (en) | Delivery devices | |
GB2405350B (en) | Delivery devices | |
GB0218126D0 (en) | Drug delivery system | |
GB0300008D0 (en) | Delivery devices | |
GB0224442D0 (en) | A delivery system | |
PL372172A1 (en) | Osmotic delivery system | |
AU2003228995A8 (en) | Content delivery system | |
GB0307999D0 (en) | A system | |
EP1667681A4 (en) | A novel transmucosal delivery system | |
GB0330163D0 (en) | Locker-bank delivery process | |
GB2389738B (en) | Mail delivery system | |
PL379424A1 (en) | Novel gum delivery systems | |
GB2385637B (en) | A package delivery system | |
GB0302276D0 (en) | Mail delivery system | |
EP1732555A4 (en) | Opioid delivery system | |
GB0315914D0 (en) | A system | |
GB0327409D0 (en) | Delivery system | |
AU2003905867A0 (en) | A Delivery System | |
GB0321533D0 (en) | A lottery system | |
GB2405649B (en) | A supporting system | |
GB2428706B (en) | A supporting system | |
GB0307020D0 (en) | Advanced parcel delivery system | |
GB0327692D0 (en) | A system | |
GB0300079D0 (en) | A system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20060330 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20090828 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 9/16 20060101ALI20090824BHEP Ipc: A61K 31/4439 20060101ALI20090824BHEP Ipc: A61K 9/20 20060101AFI20090824BHEP |
|
17Q | First examination report despatched |
Effective date: 20091126 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20110802 |